ClinicalTrials.Veeva

Menu

Effect of Different Remineralizing Agents on White Spot Lesions Treatment in Children (RCT)

N

National Research Centre, Egypt

Status

Completed

Conditions

White Spot Lesion of Tooth

Treatments

Drug: Casein phosphopeptide-amorphous calcium phosphate + fluoride
Drug: Casein phosphopeptide-amorphous calcium phosphate
Drug: Nano hydroxyapatite paste
Drug: Fluoride gel

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

One hundred children with white spot lesions on their teeth were divivided into 5 groups of different remineralizing agents to assess their effect on color change and remineralization

Full description

Children having at least one tooth clinically diagnosed by white spot lesion were randomly allocated to five groups.

Group one: No treatment was applied (negative control). Group two: Fluoride gel was applied for 5 minutes (positive control). Group three: Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) (MI paste) was applied for 5 minutes.

Group four: Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) + fluoride (MI paste plus) were applied for 5 minutes.

Group five: Nano hydroxyapatite paste (Apagard primo toothpaste) was be applied for 5 minutes.

All children involved in this study were instructed to brush their teeth under the supervision of the researcher before the application of the studied agent.

Each agent was applied to the labial surfaces of each tooth affected with white spot lesion for 5 minutes after cleaning and drying with a cotton roll using an applicator tip. After each application, children were instructed not to eat or drink for one hour. This application was be repeated in-office after one then after two weeks then after six weeks.

Participants received a sterilized pouch containing a sterile container with one of the pastes according to the study group for home application. The application of the paste was carried out under parental supervision and was asked to apply each of the pastes at home three times a day till the end of the study

Enrollment

100 patients

Sex

All

Ages

10 to 14 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Presence of at least one tooth affected by white spot lesion.
  2. Good oral hygiene and regular tooth brushing at least twice daily.

Exclusion criteria

  1. Unwillingness to be randomly assigned to 1 of the 3 treatment groups.
  2. Presence of abnormal oral, medical, or mental condition.
  3. Presence of any milk-related allergies.
  4. Presence of dentin caries or enamel hypoplasia on maxillary anterior teeth.
  5. Presence of periodontal pockets around maxillary anterior teeth.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Triple Blind

100 participants in 5 patient groups

No treatment
No Intervention group
Description:
Negative control
Fluoride gel
Active Comparator group
Description:
Positive control
Treatment:
Drug: Fluoride gel
Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) (MI paste)
Experimental group
Description:
Intervention
Treatment:
Drug: Casein phosphopeptide-amorphous calcium phosphate
Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) + fluoride (MI paste plus)
Experimental group
Description:
Intervention
Treatment:
Drug: Casein phosphopeptide-amorphous calcium phosphate + fluoride
Nano hydroxyapatite paste (Apagard primo toothpaste)
Experimental group
Description:
Intervention
Treatment:
Drug: Nano hydroxyapatite paste

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems